The GC cells treated with TGF-β1 enhanced the colonies, OD levels and N-cadherin and Vimentin mRNA levels, and weakened E-cadherin mRNA levels through colony formation, CCK-8, and EMT assays, respectively (Fig. 7A–C). The gene discussed is CDH2; the disease is gastric cancer.